Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation
Authors:
- A. RansierARA. Ransier
- C.H. SherlockCSC.H. Sherlock
- J.J. SpinelliJSJ.J. Spinelli
- D. ReeceDRD. Reece
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier in Oral Oncology
- Vol. 32 (3) , 158-162
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Failure of Clindamycin to Influence the Course of Severe Oromucositis Associated with Streptococcal Bacteraemia in Allogeneic Bone Marrow Transplant RecipientsScandinavian Journal of Infectious Diseases, 1993
- Viral Serology After Bone Marrow TransplantationViral Immunology, 1991
- Chemoprophylaxis of viral infection in immunocompromised patientsEuropean Journal of Cancer and Clinical Oncology, 1989
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Successful Treatment with Foscarnet of an Acyclovir-Resistant Mucocutaneous Infection with Herpes Simplex Virus in a Patient with Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Acyclovir-Resistant Herpes Simplex Virus Infections in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Significance of resistance of herpes simplex virus to acyclovirJournal of the American Academy of Dermatology, 1988
- The role of an immunoperoxidase technique in the diagnosis of oral herpes simplex virus infection in patients with leukemiaDiagnostic Cytopathology, 1987
- Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: Correlation of viral susceptibilities and plasma levels with response to therapyDiagnostic Microbiology and Infectious Disease, 1987